Chris Degnan
CIK 1741968 · Chief Financial Officer · last filed 2026-02-03
Chris Degnan is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for URGN, was dated Feb 3, 2026. Across all open-market trades the lifetime net is +$27.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $85.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$85.0K
3
11
$27.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| URGN | Chief Financial Officer | 2,280 | $29.72 | $67.8K | -$37.1K | 3 | 2026-02-03 |
| Galera Therapeutics, Inc. (GRTX) Delisted | Chief Financial Officer | 10,000 | $0.14 | $1.4K | $19.6K | 6 | 2023-03-14 |
| VRCA | Chief Financial Officer | 3,000 | $5.73 | $17.2K | $45.0K | 2 | 2019-03-04 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | URGN | Grant (A) | — | $0 | EDGAR |
| 2025-10-09 | URGN | Mixed | +2,280 | -$37.1K | EDGAR |
| 2024-10-09 | URGN | Grant (A) | — | $0 | EDGAR |
| 2023-03-14 | Galera Therapeutics, Inc. (GRTX) Delisted | Buy (P) | +10,000 | $19.6K | EDGAR |
| 2023-02-28 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-28 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-08 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-04 | VRCA | Grant (A) | — | $0 | EDGAR |